News Aktuell

LTS Lohmann Therapie-Systeme AG

28.02.2024 - 13:00

First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US

Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, announced today that its customer Coherus BioSciences, Inc (“Coherus”) has launched its UDENYCA® on-body injector (OBI) utilizing the ...To the press release of LTS Lohmann Therapie-Systeme AG

One image:
Preview HiResDownload

19.12.2023 - 13:00

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

Andernach (ots) - LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The purpose of the grant is to support the development of microneedle array patches (MAP) for ...To the press release of LTS Lohmann Therapie-Systeme AG

One image:
Preview HiResDownload

06.12.2023 - 16:00

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

Andernach (ots) - LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The grant will support new formulation methods for mRNA, such as dissolvable microneedle array ...To the press release of LTS Lohmann Therapie-Systeme AG

One image:
Preview HiResDownload

08.06.2023 - 17:00

LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business

Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro ...To the press release of LTS Lohmann Therapie-Systeme AG

One image:
Preview HiResDownload